• tis. maj 18th, 2021

Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions


apr 21, 2021

This document aims to provide interim guidance on the risks for fully vaccinated individuals to develop or transmit
infection that will give rise to severe COVID-19 disease in the context of the current epidemiological and vaccine
coverage situation in the EU/EEA. Läs artikeln här!

Lämna ett svar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *

error: Content is protected !!